Abstract
Age-related changes in pharmacokinetics principally affect drug absorption, distribution, metabolism and elimination. Changes in pharmacodynamics are primarily seen in the cardiovascular and neuroendocrine system. Age-dependent changes in the kinetics and dynamics of drugs acting on the cardiovascular system and central nervous system are common, and this review, while by no means exhaustive of the effects of drugs on all organ systems, is reflective of the principles and gives examples of the effects of age on these 2 major systems. While pharmacokinetic changes in the elderly are usually well characterised, pharmacodynamic changes are understood only in the most preliminary way. There has been relatively little research in this area of geriatric clinical pharmacology, and pharmacodynamic changes are still an area of investigation.
Similar content being viewed by others
References
Baum C, Kennedy D, Forbes M, et al. Drag use in the United States in 1981. JAMA. 1981; 251: 1293–7.
Shock N. Normal human aging: the Baltimore Longitudinal Study of Aging [Publication No. 84]. Washington, DC: US Government Printing Office, 1984: 2450.
Turner N, Scarpace PJ, Lowenthal DT. Geriatric pharmacology: basic and clinical considerations. Annu Rev Pharmacol Toxicol. 1992; 32: 271–302.
Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly: therapeutic considerations: Pt I. Clin Pharmacokinet. 1991; 21(3): 165–77.
Delafuente JC. Perspectives on geriatric pharmacotherapy. Pharmacotherapy. 1991; 11(3): 222–4.
Colt HG, Shapiro AP. Drug-induced illness as a cause for admission to a community hospital [see comments]. J Am Geriatr Soc. 1989; 37(4): 323–6.
Vestal RE, Wood AJ, Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther. 1979; 26(2): 181–6.
Bender A. Effect of age on intestinal absorption: implications for drug absorption in the elderly. J Am Geriatr Soc. 1968; 16: 1331–9.
Geokas M, Haverback B. The aging gastrointestinal tract. Am J Surg. 1969; 117: 881–92.
Richey D, Bender A. Pharmacokinetics consequences of aging. Annu Rev Pharmacol Toxicol. 1977; 17: 49–65.
Evans M, Triggs E, Cheung M, et al. Gastric emptying rate in the elderly: implications for drug therapy. J Am Geriatr Soc. 1981; 29: 201–5.
Bender A. The effect of increasing age on the distribution of peripheral blood flow in man. J Am Geriatr Soc. 1965; 13: 192–8.
Evans M, Triggs E, Broe G, et al. Systemic availability of orally administered L-dopa in the elderly parkinsonian patient. Eur J Clin Pharmacol. 1980; 17: 215–21.
Castleden C, George C. The effect of aging on the hepatic clearance of propranolol. Br J Clin Pharmacol. 1979; 7: 49–54.
Larsson M, Landahl S, Lundborg P, et al. Pharmacokinetics of metoprolol in healthy, elderly, non-smoking individuals after a single dose and two weeks of treatment. Eur J Clin Pharmacol. 1984; 27: 217–22.
Ho P, Triggs E. Drug therapy in the elderly. Aust NZ J Med. 1984; 14: 179–90.
Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker, 1982.
Peck C. Bedside clinical pharmacokinetics. Rockville (MD): Pharmacometric Press, 1985.
Collart P, Poitevin M, Milovanovic A, et al. Kinetic, study of, serum penicillin concentrations after single doses of benzathine and benethamine penicillins in young and old people. Br J Vener Dis. 1980; 56: 355–62.
Douglas J, Bax R, Munro J. The pharmacokinetics of cefuroxime in the elderly. J Antimicrob Chemother. 1980; 6: 543–9.
Phillips S, Bararaman-Phillips J. The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing-home acquired pneumonia. J Am Geriatr Soc. 1993; 4: 1071–4.
Shock N, Watkin D, Yiengst B, et al. Age differences in water content of the body as related to basal oxygen consumption in males. J Gerontol. 1963; 18: 1–8.
Forbes G, Reina J. Adult lean body mass declines with age: some longitudinal observations. Metabolism. 1970; 19: 653–63.
Adelman L, Liebman J. Anatomy of body water and electrolytes. Am J Med. 1959; 27: 256–77.
Lowenthal D. Clinical pharmacology. In: Abrams W, Berkow R, editor. Merck manual of geriatrics. Rahway (NJ): Merck & Co Inc, 1990.
Lakatta E. Age-related alteration in the cardiovascular response to adrenergic-mediated stress. Fed Proc. 1980; 39: 3173–7.
Campion EW, deLabry LO, Glynn RJ. The effect of age on serum albumin in healthy males: report from the normative aging study. J Gerontol. 1988; 43(1): M18–20.
Schmucker D. Aging and drug disposition: an update. Pharmacol Rev. 1985; 37: 133–48.
Wallace S, Whiting B. Factors affecting drug binding in plasma of elderly patients. Br J Clin Pharmacol. 1976; 3: 327–30.
Paxton J. Alpha 1 acid glycoprotein and binding of basic drugs. Methods Find Exp Clin Pharmacol. 1983; 5: 635.
Piafsky K. Disease induced changes in the plasma binding of basic drugs. Clin Pharmacokinet. 1980; 5: 246–62.
O’Malley K, Crooks J, Duke E, et al. Effects of age and sex on human drug metabolism. BMJ. 1971; 3: 607–9.
Vestal R, Wood A, Branch R, et al. Effect of age and cigarette smoking on propranolol disposition. Clin Pharmacol Ther. 1979; 26: 8–15.
Bach B, Hansen J, Kampmann J, et al. Disposition of antipyrine and phenytoin correlated with age and liver volume in men. Clin Pharmacokinet. 1981; 6: 389–96.
Crooks J, Stephenson I. Drugs and the elderly. London: Macmillan, 1979.
Sotaniemi EA, Arranto AJ, Pelkonen O, et al. Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions. Clin Pharmacol Ther. 1996; 61(3): 331–9.
Schmucker DL, Woodhouse KW, Wang RK, et al. Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther. 1990; 48(4): 365–74.
Yuen G. Altered pharmacokinetics in the elderly. Clin Geriatr Med. 1990; 6: 257–67.
Divoll M, Abernethy D, Ameer B, et al. Acetaminophen kinetics in the elderly. Clin Pharmacol Ther. 1982; 31: 151–6.
Abernethy D, Greenblatt D, Shader R. Imipramine and desipramine disposition in the elderly. J Pharmacol Exp Ther. 1985; 232: 183–8.
Wood A, Vestal R, Wilkinson G, et al. The effect of aging and cigarette smoking on the elimination of antipyrine and indocyanine green elimination. Clin Pharmacol Ther. 1979; 26: 16–20.
Twun-Barima Y, Finnigan T, Habash A, et al. Impaired enzyme induction by rifampicin in the elderly [letter]. Br J Clin Pharmacol. 1984; 17: 595–7.
Davies D, Shock N. Age changes in glomerular filtration rates, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest. 1950; 29: 496–507.
Rowe J, Andres R, Tobin J, et al. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol. 1976; 31: 155–63.
Landahl S, Aurell M, Jagenburg R. Glomerular filtration rate at the age of 70 and 75. J Clin Exp Gerant. 1982; 3: 29–45.
Watkin D, Shock N. Agewise standard value for Cin, Cpah and Tmpah in adult males. J Clin Invest. 1955; 34: 965.
Trollfors B, Norrby R. Estimation of glomerular filtration rate by serum creatinine and serum beta-2-microglobulin. Nephron. 1981; 28: 196–9.
Kim K, Onesti G, Ramirez O, et al. Creatinine clearance in renal disease: a reappraisal. BMJ. 1969; 4: 11–4.
Cockroft D, Gault M. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31–41.
Baum C, Kennedy D, Forbes M. Utilization of nonsteroidal antiinflamatory drugs. Arthritis Rheum. 1985; 28: 686–92.
Taha A, Lenton R, Murdoch P, et al. Non-oliguric renal failure during treatment with mefenamic acid in elderly patients: a continuing problem. Br Med J Clin Res Ed. 1985; 291: 661–2.
Unworth J, Sturman S, Lunec J, et al. Renal impairment associated with nonsteroidal antiinflamatory drugs. Ann Rheum Dis. 1987; 46: 233–6.
Ciabattoni G, Cinotti G, Pierucci A, et al. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. N Engl J Med. 1984; 310: 279–83.
Murray M, Brater D. Nonsteroidal antiinflammatory drugs. Clin Geriatr Med. 1990; 6: 365–97.
Cornoni-Huntley J, Brock D, Ostfeldt A, et al. Established populations for epidemiologic studies of the elderly. Resource data book [publication no. 86]. Washington, DC: US Government Printing Office, 1986: 2443.
Feely J, Coakley D. Altered pharmacodynamics in the elderly. Clin Geriatr Med. 1990; 6(2): 269–83.
Lippa AS PR, Beer B, Critchet DJ, et al. Brain cholinergic dysfunction and memory in aged rats. Neurobiol Aging. 1980; 1: 13–9.
Abrass IB, Davis JL, Scarpace PJ. Isoproterenol responsiveness and myocardial beta-adrenergic receptors in young and old rats. J Gerontol. 1982; 37(2): 156–60.
Roth G, Hess G. Changes in the mechanisms of hormone neurotransmitter action during aging. Current status of the role of receptor and postreceptor alterations: a review. Mech Ageing Dev. 1982; 20: 175–94.
Guarnieri T, Filburn CR, Zitnik G, et al. Contractile and biochemical correlates of beta-adrenergic stimulation of the aged heart. Am J Physiol. 1980; 239(4): H501–8.
Shimazu T, Takeda A, Fukushima Y. Neural-metabolic interaction in the liver during aging in rats. In: Kitani K, editor. Liver and aging. Amsterdam: Elsevier, 1986: 171–81.
Borst S, Scarpace P. Reduced high-affinity alpha 1-adrenoceptors in liver of senescent rats: implications of assessment at various temperatures. Br J Pharmacol. 1990; 101: 650–4.
Morley J, Flood J, Silver A. Opioid peptides and aging. Ann NY Acad Sci. 1990; 579: 123–32.
Roth G. Mechanisms of altered hormone-neurotransmitter action during aging: from receptors to calcium mobilization. Ann Rev Gerontol Geriatr. 1990; 10: 132–46.
Peterson C. Changes in calcium’s role as messenger during aging in neuronal and nonneuronal cells. Ann NY Acad Sci. 1992; 663: 279–93.
Castleden CM, George CF, Marcer D, et al. Increased sensitivity to nitrazepam in old age. BMJ. 1977; I: 10–12.
Larsson E, Kukull W, Buchner D, et al. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med. 1987; 107: 169–73.
Bender A. Pharmacologic aspects of aging: a survey of the effect of age on drug activity in adults. J Am Geriatr Soc. 1964; 12: 114–34.
Kallman H. Depression in the elderly. Compendium of three years of clinical use. Proceedings of Symposium on Desyrel®. 1984 Sep 14; Evansville (IL): Mead-Johnson Pharmaceut Division, 1985: 31–40.
Gribbin B, Pickering T, Sleight P, et al. Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res. 1971; 29: 424–31.
McGarry K, Laher M, Fitzgerald D, et al. Baroreflex function in elderly hypertensives. Hypertension. 1975; 5: 763–6.
Schatz I. Orthostatic hypotension: I. Functional and neurogenic causes. Arch Intern Med. 1984; 144: 773–7.
Schatz I. Orthostatic hypotension: II. Clinical diagnosis, testing and treatment. Arch Intern Med. 1984; 144: 1037–41.
Come P, Pitt B. Nitroglycerin-induced severe hypotension and bradycardia in patients with acute myocardial infarction. Circulation. 1976; 54: 624–8.
Alpert J. Nitrate therapy in the elderly. Am J Cardiol. 1990; 65: 23J–7J.
Weidmann P, De Myttenaere-Bursztein S, Maxwell M, et al. Effect of aging on plasma renin and aldosterone in normal man. Kidney Int. 1975; 8: 325–33.
Epstein M, Hollenberg N. Age as a determinant of renal sodium conservation in normal man. J Lab Clin Med. 1976; 87: 411–7.
Buhler F, Hulthen U, Kiowski W, et al. The place of the calcium antagonist verapamil in antihypertensive therapy. J Cardiovasc Pharmacol. 1982; 4 Suppl. 3: 5350–7.
Shannon R, Minaker K, Rowe J. Aging and water balance in humans. Semin Nephrol. 1984; 4: 346–53.
Rowe J, Shock N, deFronzo R. The influence of age on the renal response to water deprivation in man. Nephron. 1976; 17: 270–8.
Lindeman R, Lee Jr T, Yiengst M, et al. Influence of age, renal disease, hypertension, diuretics and calcium on the antidiuretic response to suboptimal infusions of vasopressin. J Lab Clin Med. 1966; 68: 206–23.
Rowe S, Minaker K, Sparrow D, et al. Age-related failure of volume-pressure-mediated vasopressin release. J Clin Endocrinol. 1982; 54: 661–4.
Geller J. Benign prostatic hyperplasia: pathogenesis and medical therapy. J Am Geriatr Soc. 1993; 39: 1208–16.
Crooks J. Aging and drug disposition: pharmacodynamics. J Chronic Dis. 1983; 36(1): 85–90.
Davies KN, Castleden CM. Ageing and receptors. In: Grimley-Evans J, Caird FI, editors. Advanced geriatric medicine. London: Wright, 1988.
Ziegler MG, Lake CR, Kopin IJ. Plasma noradrenaline increases with age. Nature. 1976; 261(5558): 333–5.
Pan H, Hoffmann B, Pershe R, et al. Decline in beta-adrenergic receptor-mediated relaxation with aging in man. J Pharmacol Exp Ther. 1986; 239: 802–7.
Ford G, Hoffmann B, Vestal R, et al. Age-related changes in adenosine and beta-adrenergic responsiveness of vascular smooth muscle in man. Br J Clin Pharmacol. 1992; 33: 83–8.
Hiremath A, Pershe R, Hoffmann B, et al. Comparison of agerelated changes in prostaglandin Ei and beta-adrenergic responsiveness of vascular smooth muscle in adult males. J Gerontol. 1989; 44: M13–7.
Brummelen P, Buhler F, Kiowski W, et al. Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects. Clin Sci. 1981; 60: 571–7.
Ford GA, James OFW. Effect of autonomic blockade on cardiac beta-adrenergic chronotropic pesponsiveness in healthy young, healthy elderly and endurance-trained elderly subjects. Clin Sci. 1994; 87: 297–302.
Abrass IB, Scarpace PJ. Catalytic unit of adenylate cyclase: reduced activity in aged-human lymphocytes. J Clin Endocrinol Metab. 1982; 55(5): 1026–8.
Scarpace PJ. Decreased receptor activation with age: can it be explained by desensitization? J Am Geriatr Soc. 1988; 36(11): 1067–71.
Conolly MJ. Aging, late-onset asthma and the beta-adrenoceptor. Pharmacol Ther. 1993; 60(3): 389–404.
Brawn LA, Castleden CM. Adverse drug reactions: an overview of special considerations in the management of the elderly patient. Drug Saf. 1990; 5(6): 421–35.
Conolly M, Crowley J, Nielson C, et al. Peripheral mononuclear leucocyte beta-adrenoceptor and non-specific bronchial responsiveness to methacholine in young and elderly normal subjects and asthmatic patients. Thorax. 1994; 49: 26–32.
Feldmann R, Limbild L, Nadeau J, et al. Alterations in leukocyte beta-receptor affinity with aging: a potential explanation for altered beta-adrenergic sensitivity in the elderly. N Engl J Med. 1984; 310: 815–9.
Sowinski K, Forrest A, Wilton J, et al. Effect of aging on atelonol pharmacokinetics and pharmacodynamics. J Clin Pharmacol. 1995; 35(8): 807–14.
Elliot H. Calcium antagonists in the treatment of hypertension and angina pectoris in the elderly. J Cardiovasc Pharmacol. 1989; 13 Suppl. 4: S12–S16.
Schwartz J, Troconiz I, Verotta D, et al. Aging effects on stereoselective pharmacokinetics and pharmacodynamics of verapamil. J Pharmacol Exp Ther. 1993; 265(2): 690–8.
Robertson D, Waller A, Renwick C, et al. Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. Br J Clin Pharmacol. 1988; 25(3): 297–305.
Donnelly R, Elliott H. Factors influencing the response to calcium antagonists in elderly patients with hypertension and ischaemic heart disease. Exp Gerontol 1990; 25 (3–4): 375–81.
Lettieri J, Krol G, Yeh S, et al. The effects of age and race on nitrendipine pharmacokinetics and pharmacodynamics. J Cardiovasc Pharmacol. 1988; 12 Suppl. 4: S129–32.
Macdonald N, Sioufi A, Howie C, et al. The effect of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril. Br J Clin Pharmacol. 1993; 36(3): 205–9.
Andros E, Detmar-Hanna D, Suteparuk S, et al. The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin. Eur J Clin Pharmacol 1996; 50 (1–2): 41–6.
Kelly J, O’Malley K. Nitrates in the elderly: pharmacological considerations. Drugs Aging. 1992; 2(1): 14–9.
Tsang P, Gerson B. Understanding digoxin use in the elderly patient. Clin Lab Med. 1990; 10(3): 479–92.
Mooradian A. Digitalis: an uptake of clinical pharmacokinetics, therapeutic monitoring techniques and treatment recommendations. Clin Pharmacokinet. 1988; 15: 165–79.
Kennedy R, Seilen E. Ouabain-sensitive 86Rb+ uptake rate and responsiveness to digoxin in rat left atrial muscle. J Pharmacol Exp Ther. 1989; 248: 104–10.
Ruiz J, Array S, Lowenthal D. Therapeutic drug monitoring in the elderly. Am J Ther. 1996; 3: 839–60.
Shepherd AM, Hewick DS, Moreland TA, et al. Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol. 1977; 4(3): 315–20.
Husted S, Andreasen F. The influence of age on the response to anticoagulants. Br J Clin Pharmacol. 1977; 4(5): 559–65.
O’Malley K, Kelly J, Swift C. Responsiveness to drugs. In: Swift C, editor. Clinical pharmacology in the elderly. New York: Marcel Dekker, 1987: 83–101.
Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA. 1989; 262: 3303–7.
Greenblatt DJ, Allen MD. Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program. Br J Clin Pharmacol. 1978; 5(5): 407–13.
Hewick DS, Shaw V. Tissue distribution of radioactivity after injection of [14C]nitrazepam in young and old rats. J Pharm Pharmacol. 1978; 30(5): 318–9.
Greenblatt DJ, Allen MD, Harmatz JS, et al. Diazepam disposition determinants. Clin Pharmacol Ther. 1980; 27(3): 301–12.
Reidenberg M, Levy M, Warner H. Relationship between diazepam ldose, plasma level, age, and central nervous system depression. Clin Pharmacol Ther. 1978; 23: 371–4.
Cook PJ, Flanagan R, James IM. Diazepam tolerance: effect of age, regular sedation, and alcohol. Br Med J Clin Res Ed. 1984; 289(6441): 351–3.
Greenblatt D, Ehrenberg B, Scavone J, et al. Increased sensitivity to midazolam in the elderly. Clin Pharmacol Ther. 1990; 47: 210.
Kanto J, Kangas L, Aaltonen L, et al. Effect of age on the pharmacokinetics and sedative effect of flunitrazepam. J Clin Pharmacol. 1981; 19: 400–4.
Memo M, Spano PF, Trabucchi M. Brain benzodiazepine receptor changes during ageing [letter]. J Pharm Pharmacol. 1981; 33(1): 64.
Bertilsson L. Geographical/interracial differences in polymorphic drug oxidation: current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharmacokinet. 1995; 29(3): 192–209.
Ozdemir V, Fourie J, Busto U, et al. Pharmacokinetic changes in the elderly: do they contribute to drug abuse and dependence? Clin Pharmacokinet. 1996; 31(5): 372–85.
Rochon PA, Gurwitz JH. Drug therapy. Lancet. 1995; 346(8966): 32–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hämmerlein, A., Derendorf, H. & Lowenthal, D.T. Pharmacokinetic and Pharmacodynamic Changes in the Elderly. Clin Pharmacokinet 35, 49–64 (1998). https://doi.org/10.2165/00003088-199835010-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199835010-00004